Shoichiro Inokuchi & Koji Shimamoto. (2024). Wnt/β-catenin pathway as a potential target for Parkinson's disease: A cohort study of romosozumab using routinely collected health data in Japan. Frontiers Media S.A..
Chicago Style (17th ed.) CitationShoichiro Inokuchi and Koji Shimamoto. Wnt/β-catenin Pathway as a Potential Target for Parkinson's Disease: A Cohort Study of Romosozumab Using Routinely Collected Health Data in Japan. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationShoichiro Inokuchi and Koji Shimamoto. Wnt/β-catenin Pathway as a Potential Target for Parkinson's Disease: A Cohort Study of Romosozumab Using Routinely Collected Health Data in Japan. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.